Selfdiagnostics STD Multitest – a next generation molecular diagnostics technology based rapid test will have its first worldwide appearance at MEDICA 2017. STD Multitest is the first and only rapid chlamydia and gonorrhoea duplex test in the world. It is painless, can be used by both sexes, provides reliable results in 30 minutes and utilises technology…
Selfdiagnostics’ work within the frames of Horizon 2020 project was evaluated by European Commission experts and an interim assessment report was recently completed. The experts found that our project is compliant with H2020 regulations and has achieved objectives and milestones set for the reporting period. Experts have confidence that Selfdiagnostics will provide results with significant immediate…
FIND, a co-op partner of the World Health Organization, has included Selfdiagnostics in their 2017-2020 project pipeline for tuberculosis diagnostics. Selfdiagnostics is one of the TOP 20 projects in the Sputum-based and drug susceptibility testing area that was given this priority status. FIND has referenced Selfdiagnostics’ technology – a lab level accurate and fully disposable rapid…
